Literature DB >> 18251991

Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Sabrina S Vollers1, Lawrence J Stern.   

Abstract

The use of major histocompatibility complex (MHC) tetramers in the detection and analysis of antigen-specific T cells has become more widespread since its introduction 11 years ago. Early challenges in the application of tetramer staining to CD4+ T cells centred around difficulties in the expression of various class II MHC allelic variants and the detection of low-frequency T cells in mixed populations. As many of the technical obstacles to class II MHC tetramer staining have been overcome, the focus has returned to uncertainties concerning how oligomer valency and T-cell receptor/MHC affinity affect tetramer binding. Such issues have become more important with an increase in the number of studies relying on direct ex vivo analysis of antigen-specific CD4+ T cells. In this review we discuss which problems in class II MHC tetramer staining have been solved to date, and which matters remain to be considered.

Mesh:

Substances:

Year:  2008        PMID: 18251991      PMCID: PMC2433336          DOI: 10.1111/j.1365-2567.2007.02801.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  96 in total

Review 1.  Challenges in staining T cells using HLA class II tetramers.

Authors:  William W Kwok
Journal:  Clin Immunol       Date:  2003-01       Impact factor: 3.969

2.  Optimization of peptide linker length in production of MHC class II/peptide tetrameric complexes increases yield and stability, and allows identification of antigen-specific CD4+T cells in peripheral blood mononuclear cells.

Authors:  Sharon L Cunliffe; Jessica R Wyer; Julian K Sutton; Michaela Lucas; Gillian Harcourt; Paul Klenerman; Andrew J McMichael; Anthony D Kelleher
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

Review 3.  Generation and use of alternative multimers of peptide/MHC complexes.

Authors:  Stéphanie Hugues; Laurent Malherbe; Christophe Filippi; Nicolas Glaichenhaus
Journal:  J Immunol Methods       Date:  2002-10-01       Impact factor: 2.303

4.  Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity.

Authors:  Andrew G Cawthon; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

Review 5.  Molecular interactions mediating T cell antigen recognition.

Authors:  P Anton van der Merwe; Simon J Davis
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

6.  Low-avidity recognition by CD4+ T cells directed to self-antigens.

Authors:  John A Gebe; Ben A Falk; Kellee A Rock; Sharon A Kochik; Anne K Heninger; Helena Reijonen; William W Kwok; Gerald T Nepom
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

Review 7.  Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes.

Authors:  Helena Reijonen; William W Kwok
Journal:  Methods       Date:  2003-03       Impact factor: 3.608

8.  In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients.

Authors:  I J M De Vries; M R Bernsen; W L van Geloof; N M Scharenborg; W J Lesterhuis; P D M Rombout; G N P Van Muijen; C G Figdor; C J A Punt; D J Ruiter; G J Adema
Journal:  Cancer Immunol Immunother       Date:  2007-04-18       Impact factor: 6.968

9.  MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.

Authors:  H Höhn; C Kortsik; I Zehbe; W E Hitzler; K Kayser; K Freitag; C Neukirch; P Andersen; T M Doherty; M Maeurer
Journal:  Scand J Immunol       Date:  2007-05       Impact factor: 3.487

10.  Human TCR-binding affinity is governed by MHC class restriction.

Authors:  David K Cole; Nicholas J Pumphrey; Jonathan M Boulter; Malkit Sami; John I Bell; Emma Gostick; David A Price; George F Gao; Andrew K Sewell; Bent K Jakobsen
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

View more
  57 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

Review 2.  Photochemical approaches to T-cell activation.

Authors:  Morgan Huse
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

3.  Cell surface display of functional human MHC class II proteins: yeast display versus insect cell display.

Authors:  Fei Wen; Dhruv K Sethi; Kai W Wucherpfennig; Huimin Zhao
Journal:  Protein Eng Des Sel       Date:  2011-07-13       Impact factor: 1.650

4.  Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research.

Authors:  Philippe Guillaume; Danijel Dojcinovic; Immanuel F Luescher
Journal:  Cancer Immun       Date:  2009-09-25

Review 5.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

6.  MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.

Authors:  Caroline Poli; Caroline Raffin; Danijel Dojcinovic; Immanuel Luescher; Maha Ayyoub; Danila Valmori
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

7.  Progression of relapsing-remitting demyelinating disease does not require increased TCR affinity or epitope spread.

Authors:  Anna E Kersh; Lindsay J Edwards; Brian D Evavold
Journal:  J Immunol       Date:  2014-09-29       Impact factor: 5.422

8.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

9.  Peptide-MHC class II complex stability governs CD4 T cell clonal selection.

Authors:  Christina K Baumgartner; Andrea Ferrante; Mika Nagaoka; Jack Gorski; Laurent P Malherbe
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

10.  DR*W201/P65 tetramer visualization of epitope-specific CD4 T-cell during M. tuberculosis infection and its resting memory pool after BCG vaccination.

Authors:  Huiyong Wei; Richard Wang; Zhuqing Yuan; Crystal Y Chen; Dan Huang; Lisa Halliday; Weihua Zhong; Gucheng Zeng; Yun Shen; Ling Shen; Yunqi Wang; Zheng W Chen
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.